Evelo Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$114,527,000 over the previous period. Total operating expenses were $108,466,000.
Profit Margin
| 2016 | 0 | -13.33M | |
|---|---|---|---|
| 2017 | 0 | -28.04M | |
| 2018 | 0 | -53.85M | |
| 2019 | 0 | -85.66M | |
| 2020 | 0 | -93.66M | |
| 2021 | 0 | -122.17M | |
| 2022 | 0 | -114.52M |
EVLO Income Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||||
Research and development | 78.55M | 83.64M | 69.61M | 63.12M | 39.88M | 19.95M | 9.13M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 108.46M | 115.39M | 91.88M | 86.35M | 58.10M | 27.53M | 13.02M |
Operating income | -108.46M | -115.39M | -91.88M | -86.35M | -58.10M | -27.53M | -13.02M |
Other income (expenses), net | -5.13M | -6.35M | -1.37M | 885K | 1.15M | -516K | -20K |
Income before tax | -113.59M | -121.74M | -93.25M | -85.47M | -56.94M | -28.04M | -13.33M |
Income tax expense | 930K | 428K | 409K | 190K | -3.09M | 215K | 287K |
Net income | -114.52M | -122.17M | -93.66M | -85.66M | -53.85M | -28.04M | -13.33M |
Earnings per share | |||||||
Basic EPS | -26.28 | -46.18 | -47.45 | -53.49 | -49.25 | -149.98 | -105.67 |
Diluted EPS | -26.28 | -46.18 | -47.45 | -53.49 | -49.25 | -149.55 | -105.67 |
| Data source | Data source | Data source | Data source | Data source |